Current Status of Hybrid PET/MRI in Oncologic Imaging.
OBJECTIVE
This review article explores recent advancements in PET/MRI for clinical oncologic imaging.


CONCLUSIONS
Radiologists should understand the technical considerations that have made PET/MRI feasible within clinical workflows, the role of PET tracers for imaging various molecular targets in oncology, and advantages of hybrid PET/MRI compared with PET/CT. To facilitate this understanding, we discuss clinical examples (including gliomas, breast cancer, bone metastases, prostate cancer, bladder cancer, gynecologic malignancy, and lymphoma) as well as future directions, challenges, and areas for continued technical optimization for PET/MRI.
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Andrew B
AB
Rosenkrantz
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Kent
K
Friedman
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Hersh
H
Chandarana
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Amy
A
Melsaether
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Linda
L
Moy
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Yu-Shin
YS
Ding
2 Department of Medicine, NYU School of Medicine, New York, NY.|3 Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Komal
K
Jhaveri
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Luis
L
Beltran
1 Department of Radiology, NYU School of Medicine, 660 First Ave, 2nd Fl, New York, NY 10016.
Rajan
R
Jain
D003287:Contrast Media; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D064847:Multimodal Imaging; D009369:Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D003287:Contrast Media; D019275:Radiopharmaceuticals
MRI; PET; cancer; hybrid PET/MRI